What is a stock summary page? Click here for an overview.
Business Description
OptiNose Inc
NAICS : 325412
SIC : 2834
ISIN : US68404V1008
Compare
Compare
Traded in other countries / regions
OPTN.USA0OP0.Germany Index Membership
Russell 2000Russell 2000Russell 3000 IPO Date
2017-10-13Description
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.66 | |||||
| Equity-to-Asset | -0.31 | |||||
| Debt-to-Equity | -3.2 | |||||
| Debt-to-EBITDA | -107.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.51 | |||||
| Beneish M-Score | -1.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.9 | |||||
| 3-Year EBITDA Growth Rate | 81 | |||||
| 3-Year EPS without NRI Growth Rate | 54 | |||||
| 3-Year FCF Growth Rate | 39.9 | |||||
| 3-Year Book Growth Rate | -0.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.64 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 19.72 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.08 | |||||
| 9-Day RSI | 80.39 | |||||
| 14-Day RSI | 78.13 | |||||
| 3-1 Month Momentum % | 52.5 | |||||
| 6-1 Month Momentum % | -18.67 | |||||
| 12-1 Month Momentum % | -29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.77 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 530.39 | |||||
| Days Sales Outstanding | 103.71 | |||||
| Days Payable | 118.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.4 | |||||
| Shareholder Yield % | -56.14 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.76 | |||||
| Operating Margin % | -20.86 | |||||
| Net Margin % | -27.54 | |||||
| FCF Margin % | -57.21 | |||||
| ROA % | -18.47 | |||||
| ROIC % | -16.26 | |||||
| 3-Year ROIIC % | 42.43 | |||||
| ROC (Joel Greenblatt) % | -28.67 | |||||
| ROCE % | -46.48 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.2 | |||||
| EV-to-EBIT | -93.84 | |||||
| EV-to-EBITDA | -115.98 | |||||
| EV-to-Revenue | 1.78 | |||||
| EV-to-Forward-Revenue | 1.72 | |||||
| EV-to-FCF | -3.11 | |||||
| Price-to-GF-Value | 0.67 | |||||
| Earnings Yield (Greenblatt) % | -1.07 | |||||
| FCF Yield % | -47.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OPTN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OptiNose Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 78.226 | ||
| EPS (TTM) ($) | -2.846 | ||
| Beta | -1.14 | ||
| 3-Year Sharpe Ratio | -0.2 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 95.76 | ||
| 14-Day RSI | 78.13 | ||
| 14-Day ATR ($) | 0.191911 | ||
| 20-Day SMA ($) | 9.1575 | ||
| 12-1 Month Momentum % | -29 | ||
| 52-Week Range ($) | 4.814999 - 20.024999 | ||
| Shares Outstanding (Mil) | 10.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OptiNose Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OptiNose Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OptiNose Inc Frequently Asked Questions
What is OptiNose Inc(OPTN)'s stock price today?
The current price of OPTN is $9.32. The 52 week high of OPTN is $20.02 and 52 week low is $4.81.
When is next earnings date of OptiNose Inc(OPTN)?
The next earnings date of OptiNose Inc(OPTN) is 2025-05-14 Est..
Does OptiNose Inc(OPTN) pay dividends? If so, how much?
OptiNose Inc(OPTN) does not pay dividend.
Guru Commentaries on NAS:OPTN
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers